Advertisement

Topics

Myeloma Canada Company Profile

22:01 EDT 21st June 2018 | BioPortfolio

Multiple myeloma, a cancer of the bone marrow, is an incurable but treatable disease. The cancer starts in plasma cells, which are produced in the bone marrow. In myeloma, abnormal plasma cells, called myeloma cells, grow uncontrollably, crowding out the normal blood cells in the bone. This can bring on symptoms such as fatigue, recurrent infections and severe pain resulting from bone fractures. The disease disturbs the body's balance of minerals and prevents organs, such as the kidney, as well as nerves, from functioning properly. In Canada, approximately 2,300 people are diagnosed with multiple myeloma every year and 1,350 patients die from the disease annually.


News Articles [518 Associated News Articles listed on BioPortfolio]

Science Saturday: Genetic testing to enhance multiple myeloma treatment

Multiple myeloma is the second most common blood cancer, but most people haven?t heard of it until they or someone they know is diagnosed with the disease. March is Myeloma Action Month ? a time to fo...

The evolution of imagining techniques for multiple myeloma

Dr Zamagni speaks to ecancer at MyKE Myeloma 2018 in Vienna about screening and imaging of myeloma. She discusses the changes in imaging techniques for multiple myeloma, noting the strengths and weak...

Diagnosis and management of smouldering myeloma

Prof Mateos talks to ecancer at MyKE Myeloma in Vienna about how to quantify the risk level for a patient with smouldering myeloma. She outlines the standard of care for patients with high-risk smoul...

Multiple Myeloma Patients, Caregivers and Health Care Professionals Trekking to the Doorstep of ...

Eighteen hikers will take on this challenge in order to raise awareness and funds for multiple myeloma through the Multiple Myeloma Research Foundation, (MMRF) Read more...

Incorporating patient perspective during myeloma treatment

Dr Ramasam speaks to ecancer at MyKE Myeloma 2018 in Vienna about the attitudes toward treatment of myeloma patients towards the end of their life. His key message is about the responsibility of comm...

Managing infections in patients with multiple myeloma

Dr Bladé speaks to ecancer at MyKE Myeloma 2018 in Vienna about infections in multiple myeloma. He discusses why infectious complications are common in this disease, and which infections are more c...

AbbVie and the International Myeloma Foundation Partner to Study Role of a Genetic Mutation in Multiple Myeloma

AbbVie a research and development-based global biopharmaceutical company, and the International Myeloma Foundation (IMF) today announced they have entered into […] The post AbbVie and the Intern...

Medical News Today: What is the first sign of multiple myeloma?

Spotting the early signs of multiple myeloma means it is easier to treat the disease. However, this type of cancer has no cure and can lead to other conditions developing. Treatment options depend on ...

Drugs and Medications [371 Associated Drugs and Medications listed on BioPortfolio]

Derma sciences [Derma Sciences Canada, Inc.]

Drug Facts

Colgate triple action original mint fluoride [Colgate-Palmolive Canada]

Colgate Triple Action Original Mint

As [CaridianBCT, Inc.]

Additive Solution Formula 3

First force [Basic Packaging Industries Inc.]

Drug Facts

Revlimid [Celgene Corporation]

These highlights do not include all the information needed to use REVLIMID safely and effectively. See full prescribing information for REVLIMID. REVLIMID (lenalidomide) capsules Initial U.S. Approval...

PubMed Articles [619 Associated PubMed Articles listed on BioPortfolio]

Pathogenesis of bone disease in multiple myeloma: from bench to bedside.

Osteolytic bone disease is the hallmark of multiple myeloma, which deteriorates the quality of life of myeloma patients, and it affects dramatically their morbidity and mortality. The basis of the pat...

Multiple Myeloma Presenting as a Superscan on 68Ga-Pentixafor PET/CT.

A 60-year-old woman diagnosed with multiple myeloma was referred for Ga-pentixafor PET/CT for evaluation of the disease. Diffuse and intense radioactivity throughout the axial and proximal appendicula...

Blocking IFNRA1 inhibits multiple myeloma-driven Treg expansion and immunosuppression.

Despite significant advances in the treatment of multiple myeloma (MM), most patients succumb to disease progression. One of the major immunosuppressive mechanisms that is believed to play a role in m...

Acute Liver Failure Associated With Pomalidomide Therapy for Multiple Myeloma.

Daratumumab resistance is frequent in advanced stage multiple myeloma patients irrespectively of CD38 expression, and is related to dismal prognosis.

Daratumumab is a promising new anti-myeloma agent. We report a single center "real world" series of multiple myeloma (MM) and amyloidosis (AL) patients treated with daratumumab.

Clinical Trials [1512 Associated Clinical Trials listed on BioPortfolio]

Multiple Myeloma Molecular Monitoring Study

The investigators will track 250 multiple myeloma patients across Canada over time, using new lab tests to evaluate their blood and bone marrow, as they receive standard of care treatment....

Nivolumab + Lenalidomide + Dexamethasone In SMM

This research study is evaluating a new drug called "nivolumab" as a possible treatment for smoldering multiple myeloma in order to prevent or postpone development of active multiple myelo...

Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of celecoxib may be effective in preventing multiple myelo...

Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission

This research is being done to find out if the investigators can improve outcomes for multiple myeloma patients by giving a myeloma vaccine to patients who are already on lenalidomide (Rev...

Pilot Study of Blinatumomab in Combination With Salvage Autologous Stem Cell Transplantation for Patients With Refractory Multiple Myeloma

This study involves receiving blinatumomab after high-dose melphalan and ASCT for multiple myeloma. The main purpose of this study is to: - To determine whether blinatumomab is safe and fe...

Companies [803 Associated Companies listed on BioPortfolio]

Myeloma Canada

Multiple myeloma, a cancer of the bone marrow, is an incurable but treatable disease. The cancer starts in plasma cells, which are produced in the bone marrow. In myeloma, abnorma...

The Multiple Myeloma Research Consortium (MMRC)

Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 38 percent, one of the lowest of all cancers. In 2011, mo...

Multiple Myeloma Research Foundation (MMRF)

Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 38 percent, one of the lowest of all cancers. In 2010, mo...

The Multiple Myeloma Research Foundation

Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 34 percent, one of the lowest of all cancers. In 2009, ap...

Multiple Myeloma Research Foundation

The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)3 non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's dia...

More Information about "Myeloma Canada" on BioPortfolio

We have published hundreds of Myeloma Canada news stories on BioPortfolio along with dozens of Myeloma Canada Clinical Trials and PubMed Articles about Myeloma Canada for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Myeloma Canada Companies in our database. You can also find out about relevant Myeloma Canada Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...


Corporate Database Quicklinks



Searches Linking to this Company Record